Buyers often search phrases like “is this peptide supplier legit?” before they have enough evidence to decide. This page is built for that moment.
As of March 17, 2026, we reviewed public claims from several peptide suppliers with visible China or Asia-linked manufacturing narratives. These notes do not certify any supplier as approved or legitimate. They show what the supplier publicly says and what a buyer should verify next.
Public claims can be useful starting points, but they are not buyer-side verification. The right question is usually not “is this supplier legit?” but “which claims matter, and what evidence should I request before committing budget?”
Public claims reviewed March 17, 2026: founded in 2001, Hangzhou operations, research-grade and cGMP peptide supply.
Open buyer-side reviewPublic claims reviewed March 17, 2026: Suzhou production, Louisville support branch, HPLC/MS testing, COAs on request.
Open buyer-side reviewPublic claims reviewed March 17, 2026: peptide and oligo CRDMO, Hangzhou manufacturing history, U.S. expansion, GMP and late-phase production focus.
Open buyer-side reviewPublic claims reviewed March 17, 2026: founded in 2009, 600+ employees, GLP lab, and FDA cGMP-compliant API manufacturing claims.
Open buyer-side reviewPublic claims reviewed March 17, 2026: listed peptide-focused pharmaceutical company, peptide API/CRO/CDMO capability, and GMP-related manufacturing claims.
Open buyer-side reviewPublic claims reviewed March 17, 2026: peptide and oligo CRDMO platform within WuXi AppTec, more than 1,600 scientists, and multi-site manufacturing claims.
Open buyer-side reviewOther current names visible in public peptide manufacturing searches include AmbioPharm, supplier-directory listings that mix CDMOs, research-peptide sellers, and trading companies. Those are worth reviewing case by case because the risk profile differs sharply between a commercial GMP CDMO and an online catalog seller.
APV does not sell peptides or broker purchases. Buyers remain responsible for qualification, purchasing, and regulatory/import compliance.